VIDEO: Eysuvis positioned as short-term solution for dry eye flares

Issue: June 25, 2021

ByTodd Bazemore

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

WAILEA, Hawaii — In this video from Hawaiian Eye 2021, Todd Bazemore, chief operating officer at Kala Pharmaceuticals, offers a company update, including the recent approval of Eysuvis (loteprednol) for dry eye disease signs and symptoms.

Published by:

Sources/Disclosures

Collapse

Source:

Todd Bazemore

Read more about

dry eye disease

loteprednol etabonate

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment